LIFESHARE PRESIDENT/CEO TO PRESENT AT INTERNATIONAL CONFERENCE
LifeShare Transplant Donor Services of Oklahoma has announced that Jeffrey Orlowski, President and Chief Executive Officer, will be presenting at the International Congress of The Transplantation Society in Hong Kong.
The Transplantation Society is an international conference with a broad program. The conference covers a diverse range of topics from cutting edge science to the latest controversies in ethics and public policy regarding transplantation.
This is the 26th International Congress of The Transplantation Society and more than 6,700 members representing 105 countries will attend.
Orlowski is presenting two abstracts at the conference, including “Experience with Donation after Circulatory Death (DCD) in Donors Aged 56-65: A Preliminary Report on Kidney Utilization and Initial Outcomes”. He will also present “Increased Consented-Not Recovered (CNR) Cases as a Consequence of Aggressive Donor Pursuit: Impact and Implications”.
Co-Authors of these abstracts are members of the LifeShare team including Janice Whaley, Executive Vice President and Chief Operating Officer; Jan Foutch, Vice President of Quality Systems; Chad Muse, Clinical Research Director and Ron Squires, Vice President and Medical Director.
“It is an honor to have the opportunity to present our research from LifeShare in an effort to educate colleagues from across the world.” Orlowski said.
The conference will be held August 18th to 23rd in Hong Kong.
The Transplantation Society is an international conference with a broad program. The conference covers a diverse range of topics from cutting edge science to the latest controversies in ethics and public policy regarding transplantation.
This is the 26th International Congress of The Transplantation Society and more than 6,700 members representing 105 countries will attend.
Orlowski is presenting two abstracts at the conference, including “Experience with Donation after Circulatory Death (DCD) in Donors Aged 56-65: A Preliminary Report on Kidney Utilization and Initial Outcomes”. He will also present “Increased Consented-Not Recovered (CNR) Cases as a Consequence of Aggressive Donor Pursuit: Impact and Implications”.
Co-Authors of these abstracts are members of the LifeShare team including Janice Whaley, Executive Vice President and Chief Operating Officer; Jan Foutch, Vice President of Quality Systems; Chad Muse, Clinical Research Director and Ron Squires, Vice President and Medical Director.
“It is an honor to have the opportunity to present our research from LifeShare in an effort to educate colleagues from across the world.” Orlowski said.
The conference will be held August 18th to 23rd in Hong Kong.
